ClinicalTrials.Veeva

Menu

The Turkish Version of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity

A

Acibadem University

Status

Completed

Conditions

Axial Spondyloarthritis

Treatments

Behavioral: Determining Barriers and Facilitators of Physical Activity

Study type

Observational

Funder types

Other

Identifiers

NCT05019547
ATADEK 2021 - 15

Details and patient eligibility

About

Our aim in this study is to translate the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors that facilitate and prevent individuals for physical activity for patients with inflammatory arthritis into Turkish language. Also, our aim is to evaluate the validity and reliability of the IFAB Questionnaire in the Turkish population, and to perform a cultural adaptation if necessary at the same time. Determining the factors that facilitate and prevent individuals for physical activity interventions with rheumatic diseases and then designing physical activity programs considering these factors may play an important role in reducing the symptoms caused by the disease and increasing their quality of life.

Enrollment

93 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being 18 years or older,
  • Diagnosed with Axial Spondyloarthritis by an experienced rheumatologist
  • To have the neurological competence and cognitive level to answer the scale questions.

Exclusion criteria

  • Having a rheumatological disease other than Axial Spondyloarthritis ,
  • Using an assistive device for walking.
  • Any verbal or written communication problems in Turkish,

Trial design

93 participants in 1 patient group

Axial Spondyloarthritis
Description:
Participants with Axial Spondyloarthritis
Treatment:
Behavioral: Determining Barriers and Facilitators of Physical Activity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems